-
1 Comment
Alkem Laboratories Limited is currently in a long term uptrend where the price is trading 15.4% above its 200 day moving average.
From a valuation standpoint, the stock is 20.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Alkem Laboratories Limited's total revenue rose by 6.2% to $23B since the same quarter in the previous year.
Its net income has increased by 18.1% to $5B since the same quarter in the previous year.
Finally, its free cash flow grew by 260.3% to $8B since the same quarter in the previous year.
Based on the above factors, Alkem Laboratories Limited gets an overall score of 5/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | NSE |
CurrencyCode | INR |
ISIN | INE540L01014 |
Market Cap | 626B |
---|---|
PE Ratio | 29.07 |
Target Price | 5365.7144 |
Dividend Yield | 0.8% |
Beta | 0.47 |
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastro-intestinal, pain/analgesic, anti-diabetic, neuro/central nervous system, gynecology, respiratory, dermatology, and cardiac diseases. It also provides vitamins, minerals, and nutrients, as well as mouth wash, shampoos, pregnancy detection kits, and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALKEM.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025